课题基金 / 基金详情

AUTOIMMUNE PHENOMENA & PSYCHOTIC RELAPSE--SCHIZOPHRENIA

AUTOIMMUNE PHENOMENA & PSYCHOTIC RELAPSE--SCHIZOPHRENIA
自身免疫现象
批准号:
3380793
负责人:
ROHAN GANGULI
金额:
$13.95万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1988-06-30

项目摘要

项目成果

ROHAN GANGULI的其他基金

相似基金

相关文献

中文摘要
翻译
这是一项研究自身免疫过程假说的建议
英文摘要
This is a proposal to investigate the hypothesis that an autoimmune process directed against brain tissue antigens might be causally related to the production of psychotic symptoms in schizophrenics. The plan to test this hypothesis is characterized by two approaches: 1) a cross-sectional study of multiple immunologic parameters in acutely psychotic schizophrenic patients, psychotic patients with Systemic Lupus Erythematosus (SLE) contrasted with schizophrenics in remission, previously unmedicated schizophrenics, nonpsychotic SLE patients, brain damaged non-psychotic patients and normal controls. This part of the investigation will show if there is a specific association between psychotic symptoms and an autoimmune anti-brain response. 2) A longitudinal follow up of the schizophrenic patients will then be carried out with frequent repeated measurements of immunologic parameters and of the level of psychotic symptomatology. This part of the investigation will reveal if the autoimmune phenomena and the level of psychotic symptoms covary and whether the autoimmune phenomena emerge before corresponding changes in clinical state. The design of the study has been derived from current models of immunopathophysiology in known autoimmune disorders such as SLE, Insulin Dependent Diabetes Mellitus and autoimmune hyperthyroidism. This study promises to answer in a definitive way questions raised by pilot data gathered by the Principal Investigator and by other studies over the last 30 years which have demonstrated an association between immune dysfunction and schizophrenia. Uncovering an autoimmune pathogenesis in even a subgroup of schizophrenics would lead to further studies of etiology in schizophrenia and also open the door to a number of novel treatment approaches based on modifying the immune response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A CLINICAL TRIAL OF WEIGHT REDUCTION IN SCHIZOPHRENIA
A CLINICAL TRIAL OF WEIGHT REDUCTION IN SCHIZOPHRENIA
A CLINICAL TRIAL OF WEIGHT REDUCTION IN SCHIZOPHRENIA
A CLINICAL TRIAL OF WEIGHT REDUCTION IN SCHIZOPHRENIA
海外基金